Navidea Biopharmaceuticals, Inc. (NAVBQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026

NAVBQ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Feb '26 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
0730572319
Market Cap Growth
-99.90%-77.52%-47.34%151.52%21.97%-67.87%
Enterprise Value
-424412115
Last Close Price
0.000.211.002.151.262.05
PS Ratio
0.16103.2456.7362.5734.6015.96
PB Ratio
0.00-0.8348.2627.97-25.847.74
P/TBV Ratio
---5.21-14.21
P/FCF Ratio
-----4.41
P/OCF Ratio
-----4.37
EV/Sales Ratio
-65.3345.3244.9632.5512.82
EV/FCF Ratio
-----3.54
Debt / Equity Ratio
-0.42-0.301.200.65-1.210.13
Debt / FCF Ratio
-----0.08
Asset Turnover
00.010.070.150.120.08
Inventory Turnover
0.150.64----
Quick Ratio
0.490.200.821.200.591.45
Current Ratio
0.560.321.021.390.761.66
Return on Equity (ROE)
---878.18%-1839.18%-1431.29%-223.51%
Return on Assets (ROA)
-107.05%-129.93%-104.67%-112.43%-122.65%-43.82%
Return on Capital Employed (ROCE)
449.20%205.60%-896.70%-352.00%-3308.40%-267.60%
Earnings Yield
-1389460.00%-223.93%-38.91%-18.73%-48.10%-86.35%
FCF Yield
-9728817.00%-133.52%-33.98%-14.52%-41.10%22.66%
Buyback Yield / Dilution
-75.79%-5.31%-22.80%-66.02%-68.80%-2.72%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.